As secondary aims, we investigated the associations of T cell proximity score with tumour and patient characteristics and the prognostic significance of spatial T cell proximity measurements separately in the tumour centre and the invasive margin, in MMR proficient and MMR deficient tumour subgroups as well as in low and high disease stage tumours. This evidence concerns the gene MRC1 and neoplasm.